Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma Article (Faculty180)

cited authors

  • Adibi, Mehrad; McCormick, Barrett; Economides, Minas P; Petros, Firas; Xiao, Lianchun; Guo, Charles; Shah, Amishi; Kamat, Ashish M; Dinney, Colin; Navai, Neema; Gao, Jianjun; Siefker-Radtke, Arlene; Matin, Surena F; Campbell, Ma T

description

  • Emerging data suggests improved outcomes in patients receiving neoadjuvant chemotherapy (NAC) prior to radical nephroureterectomy (RNU) for high-risk upper tract urothelial carcinoma. In one of the largest single-center experiences to date, we provide an updated analysis of outcomes of patients receiving NAC followed by RNU.

authors

publication date

  • 2022

published in

start page

  • 176

end page

  • 182

volume

  • 20